You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 9, September 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Age at onset of necrotizing enterocolitis. Risk factors in small infants

R. Wilson, W. P. Kanto Jr, B. J. McCarthy and R. A. Feldman

We compared the features of 45 infants with early-onset necrotizing enterocolitis (NEC) (in the first ten days of life) and 41 infants with late-onset NEC (after the tenth day of life); all weighed 1,500 g or less at birth. Infants with late-onset NEC were smaller at birth and had younger gestational ages than infants with early-onset illness. No significant differences between the two groups, however, were found in sex or race distribution, mean one- and five-minute Apgar scores, or in the relative frequency of occurrence of 30 maternal and neonatal risk factors. Intravenous alimentation was administered significantly more frequently to infants with late-onset NEC. Birth weight-specific weekly attack rates for NEC declined dramatically when infants reached the equivalent of 35 to 36 weeks' gestational age. We hypothesize that the timing of noxious events in relation to gut maturity may explain these observations.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intestinal and hepatic expression of BNIP3 in necrotizing enterocolitis: regulation by nitric oxide and peroxynitrite
Zamora et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2005;289:G822-G830.
ABSTRACT | FULL TEXT  

High-mobility group box 1 protein is an inflammatory mediator in necrotizing enterocolitis: protective effect of the macrophage deactivator semapimod
Zamora et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2005;289:G643-G652.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.